MELANIE STONER: Open Payments
NPI 1851330542 · MIFFLINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 76 payments from 19 companies in 2025. Trend: 2023 $1,316 · 2024 $1,229 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $173 |
| PFIZER INC. | 17 | $148 |
| Lilly USA, LLC | 4 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Dexcom, Inc. | 3 | $78 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Novo Nordisk Inc | 4 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
Products named: ELIQUIS, JARDIANCE, ZEPBOUND, QULIPTA, Dexcom G6 Transmitter, VRAYLAR, CAPLYTA, Ozempic.
Industry payments across PA — which companies pay providers there.
